Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Hypertonic saturated saline** is a topical oral-rinse formulation of sodium chloride in water at saturation, producing a highly hypertonic solution. It was evaluated in an investigator-sponsored, randomized blinded Phase 2 study as a 30-minute mouth rinse without gargling for people with COVID-19, with the intended purpose of reducing upper respiratory or nasopharyngeal SARS-CoV-2 viral load and related symptoms. Its proposed activity is local and physicochemical rather than receptor-mediated: high sodium chloride concentration creates marked osmotic and ionic conditions that were hypothesized to reduce viral burden in the oral and nasopharyngeal cavity. The registered study NCT04842721 was withdrawn, and this formulation is not an established or approved COVID-19 treatment. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04842721))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hypertonic saturated saline.